Impact Of Clinical Pharmacist Intervention By Using Digital Technology On Clinical Outcomes Among Pregnant Women: Rationality Of Drug Prescriptions At A Tertiary Hospital In Kelantan
Pregnant women need unique pharmaceutical and medical care to avoid any harmful and birth defects. Three main objectives were assessed in this study which were measuring the impact of an educational program using WhatsApp on pregnant women knowledge, perceptions, practice, drug adherence, health...
Saved in:
| Main Author: | |
|---|---|
| Format: | Thesis |
| Language: | English |
| Published: |
2019
|
| Subjects: | |
| Online Access: | http://eprints.usm.my/55723/1/Sami%20Ph.D.%20Thesis%20cut.pdf http://eprints.usm.my/55723/ |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Summary: | Pregnant women need unique pharmaceutical and medical care to avoid any harmful
and birth defects. Three main objectives were assessed in this study which were measuring
the impact of an educational program using WhatsApp on pregnant women knowledge,
perceptions, practice, drug adherence, health literacy, and diabetic and/or hypertensive
participants’ clinical outcomes as well as measuring healthcare professionals’ knowledge,
practice, and teratogenicity risk perceptions towards medications used during pregnancy.
The last aim was to evaluate the rational drugs’ prescribing pattern at the gynecology
department using WHO/INRUD drug prescribing indicators. Methodology: Three
methodologies were used in this study. A randomized control trial was used in assessing the
impact of an educational program on pregnant women. Where 800 patients were randomly
divided into intervention and control groups. By using WhatsApp application, an
educational program was sent to all participants whereas a tailored educational program was
sent only to pregnant patients with diabetes and/or hypertension. All study domains were
measured using a pre-validated questionnaire and data collection sheet before, after and at
one month after the end of the education. A pre-validated questionnaire was distributed to
all healthcare providers and pharmacists at the gynecology department to measure their
knowledge, perceptions, and teratogenicity risk perceptions towards medications use during
pregnancy. Finally, a total of 741 prescriptions were randomly selected from patients’
medical files and analyzed using WHO/INRUD drug prescribing indicators. Appropriate
data analysis was made using SPSS version 22. |
|---|